Literature DB >> 12393885

Mitochondrial localization of mutant superoxide dismutase 1 triggers caspase-dependent cell death in a cellular model of familial amyotrophic lateral sclerosis.

Hideyuki Takeuchi1, Yasushi Kobayashi, Shinsuke Ishigaki, Manabu Doyu, Gen Sobue.   

Abstract

The mutations in superoxide dismutase 1 (SOD1) cause approximately 20% of familial amyotrophic lateral sclerosis cases. A toxic gain of function has been considered to be the cause of the disease, but its molecular mechanism remains uncertain. To determine whether the subcellular localization of mutant SOD1 is crucial to mutant SOD1-mediated cell death, we produced neuronal cell models with accumulation of SOD1 in each subcellular fraction/organelle, such as the cytosol, nucleus, endoplasmic reticulum, and mitochondria. We showed that the localization of mutant SOD1 in the mitochondria triggered the release of mitochondrial cytochrome c followed by the activation of caspase cascade and induced neuronal cell death without cytoplasmic mutant SOD1 aggregate formation. Nuclear and endoplasmic reticulum localization of mutant SOD1 did not induce cell death. These results suggest that the localization of mutant SOD1 in the mitochondria is critical in the pathogenesis of mutant SOD1-associated familial amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393885     DOI: 10.1074/jbc.M209356200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  Import, maturation, and function of SOD1 and its copper chaperone CCS in the mitochondrial intermembrane space.

Authors:  Hibiki Kawamata; Giovanni Manfredi
Journal:  Antioxid Redox Signal       Date:  2010-11-01       Impact factor: 8.401

2.  Structural consequences of the familial amyotrophic lateral sclerosis SOD1 mutant His46Arg.

Authors:  Svetlana Antonyuk; Jennifer Stine Elam; Michael A Hough; Richard W Strange; Peter A Doucette; Jorge A Rodriguez; Lawrence J Hayward; Joan Selverstone Valentine; P John Hart; S Samar Hasnain
Journal:  Protein Sci       Date:  2005-05       Impact factor: 6.725

Review 3.  The mitochondrial permeability transition in neurologic disease.

Authors:  M D Norenberg; K V Rama Rao
Journal:  Neurochem Int       Date:  2007-03-04       Impact factor: 3.921

Review 4.  Mitochondrial dysfunction in amyotrophic lateral sclerosis.

Authors:  Ping Shi; Jozsef Gal; David M Kwinter; Xiaoyan Liu; Haining Zhu
Journal:  Biochim Biophys Acta       Date:  2009-08-26

5.  Estrogen receptor mediates a distinct mitochondrial unfolded protein response.

Authors:  Luena Papa; Doris Germain
Journal:  J Cell Sci       Date:  2011-04-12       Impact factor: 5.285

6.  Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS).

Authors:  James C Stevens; Ruth Chia; William T Hendriks; Virginie Bros-Facer; Jan van Minnen; Joanne E Martin; Graham S Jackson; Linda Greensmith; Giampietro Schiavo; Elizabeth M C Fisher
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

Review 7.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

Review 8.  The human G93A-superoxide dismutase-1 mutation, mitochondrial glutathione and apoptotic cell death.

Authors:  H Muyderman; P G Hutson; D Matusica; M-L Rogers; R A Rush
Journal:  Neurochem Res       Date:  2009-04-28       Impact factor: 3.996

Review 9.  Mitochondrial degeneration in amyotrophic lateral sclerosis.

Authors:  Zuoshang Xu; Cheowha Jung; Cynthia Higgins; John Levine; Jiming Kong
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

10.  Isolated cytochrome c oxidase deficiency in G93A SOD1 mice overexpressing CCS protein.

Authors:  Marjatta Son; Scot C Leary; Nadine Romain; Fabien Pierrel; Dennis R Winge; Ronald G Haller; Jeffrey L Elliott
Journal:  J Biol Chem       Date:  2008-03-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.